• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Concerns grow over risk of rare heart condition from COVID-19 vaccine in young men

Mary Wilson

Well-known member
PUBLISHED JUNE 12, 2021 UPDATED JUNE 14, 2021
WENCY LEUNG

Canadian health authorities say they are monitoring reports of heart inflammation following mRNA COVID-19 vaccines, which are produced by Pfizer and Moderna, after U.S. officials reported a higher-than-expected number of cases in those who had received second doses.

Health Canada said a small number of these cases have been reported in Canada, but it is not yet known whether there is any link between them and mRNA vaccines. It added that it encouraged people to get immunized with any of the authorized and available vaccines.

... On Thursday, the U.S. Centers for Disease Control and Prevention (CDC) and Food and Drug Administration (FDA) presented data that showed heart conditions were rare. But they were more frequent than the two agencies would normally expect among individuals aged 16 to 24. The cases were more common among males, especially after a second dose.

https://www.theglobeandmail.com/can.../+Media&utm_campaign=Shared+Web+Article+Links
 
Back
Top